GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,708,733 | -31.2% | 3,617,080 | -0.1% | 0.22% | -22.2% |
| Q2 2023 | $19,911,540 | +27.9% | 3,620,280 | 0.0% | 0.28% | +25.7% |
| Q1 2023 | $15,567,204 | +9.2% | 3,620,280 | -0.2% | 0.23% | +19.6% |
| Q4 2022 | $14,255,210 | -26.0% | 3,627,280 | 0.0% | 0.19% | -31.5% |
| Q3 2022 | $19,261,000 | -19.1% | 3,627,280 | 0.0% | 0.28% | -17.9% |
| Q2 2022 | $23,795,000 | -12.0% | 3,627,280 | -1.5% | 0.34% | +7.0% |
| Q1 2022 | $27,027,000 | -1.4% | 3,682,180 | -4.9% | 0.31% | +11.0% |
| Q4 2021 | $27,416,000 | -55.8% | 3,872,180 | +56.6% | 0.28% | -55.0% |
| Q3 2021 | $61,977,000 | -7.0% | 2,472,180 | -0.2% | 0.63% | -3.4% |
| Q2 2021 | $66,664,000 | -2.1% | 2,478,180 | +3.6% | 0.65% | -9.7% |
| Q1 2021 | $68,110,000 | +3.0% | 2,393,180 | +2.6% | 0.72% | -4.9% |
| Q4 2020 | $66,146,000 | +13.8% | 2,333,180 | +24.1% | 0.76% | -5.6% |
| Q3 2020 | $58,111,000 | +92.2% | 1,880,000 | +30.6% | 0.80% | +87.6% |
| Q2 2020 | $30,240,000 | – | 1,440,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |